Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
AssigneePrutech Research And Development
InventorsMark D. Cochran, Christina H. Chiang, Richard D. MacDonald
Life of this patent
Estimating the term…
Abstract
The present invention provides a recombinant fusion protein comprising an antigenic amino acid sequence fused to at least a portion of the gpX glycoprotein from pseudorabies virus. Such a protein may be formulated into a vaccine and delivered to an animal using a live herpesvirus vector adapted to express the fusion protein.
Claims7
An attenuated, hybrid, nonprimate herpesvirus, designated S-PRV-055 and deposited under ATCC Accession No. VR 2179.
An attenuated, pseudorabies virus designated S-PRV-065 and deposited under ATCC Accession No. VR 2215.
An attenuated, hybrid, nonprimate herpesvirus designated S-PRV-086 and deposited under ATCC No. VR 2216.
An attenuated, hybrid, nonprimate herpesvirus designated S-PRV-040 and deposited under ATCC No. VR 2214.
An attenuated, hybrid, nonprimate herpesvirus designated S-PRV-098 and deposited under ATCC No. VR 2219.
An attenuated, hybrid, nonprimate herpesvirus designated S-PRV-088 and deposited under ATCC No. VR 2217.
An attenuated, hybrid, nonprimate herpesvirus designated S-PRV-093 and deposited under ATCC No. VR 2218.
Dependencies are inferred from the claim text.